Login / Signup

Response to Modabber and Harissi-Dagher's Letter: "Type 1 Boston Keratoprosthesis for Limbal Stem Cell Deficiency in Epidermolysis Bullosa".

N Geetha SravaniAshik MohamedVirender Singh Sangwan
Published in: Ocular immunology and inflammation (2018)
Keyphrases
  • stem cells
  • replacement therapy
  • cell therapy
  • mesenchymal stem cells